Human medicines European public assessment report (EPAR): Vumerity, diroximel fumarate, Date of authorisation: 15/11/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Vumerity, diroximel fumarate, Date of authorisation: 15/11/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn

Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – September 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 September 2025, 10:00 (CEST) to 24 September 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – September 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 September 2025, 10:00 (CEST) to 24 September 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – April 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 April 2025, 10:00 (CEST) to 29 April 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – April 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 April 2025, 10:00 (CEST) to 29 April 2025, 12:00 (CEST)

Questions and answers clinic on post-authorisation procedure management in IRIS - 17 Jan 2025, Online, from 17 January 2025, 10:00 (CET) to 17 January 2025, 11:00 (CET)

Questions and answers clinic on post-authorisation procedure management in IRIS - 17 Jan 2025, Online, from 17 January 2025, 10:00 (CET) to 17 January 2025, 11:00 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.